ClinConnect ClinConnect Logo

Main Menu

Search for Trials
For HCPs
For Industry
Blog
Contact Us
Dark Mode
Log in Sign up
Search / Trial NCT00000388

Multimodal Treatment Study of Children With Attention Deficit and Hyperactivity Disorder (MTA)

Launched by NYU LANGONE HEALTH · Nov 2, 1999

Download PDF Apply for Trial

Trial Information

Current as of May 18, 2025

Completed

Keywords

Attention Deficit Disorder With Hyperactivity Adolescence Child Cognition Combined Modality Therapy Female Human Male Peer Group Risk Factors Treatment Outcome Attention Deficit Disorder With Hyperactivity *Therapy Attention Deficit Disorder With Hyperactivity Drug Therapy Attention Deficit Disorder With Hyperactivity Psychology

ClinConnect Summary

This trial is a continuation of the Multimodal Treatment Study of Children with Attention Deficit Hyperactivity Disorder (MTA Study). Continuation Aim 1 is to track the persistence of intervention-related effects as the MTA sample matures into mid-adolescence, including subsequent mental-health and school-related service utilization patterns as a function of MTA treatment experience (treatment assignment) and outcome (degree of treatment success at 14 mo.). Aim 2 is to test specific hypotheses about predictors, mediators, and moderators of long-term outcome among children with ADHD (e.g., c...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • -
  • Patients must have:
  • • Rigorously diagnosed Attention Deficit Hyperactivity Disorder (ADHD).

About Nyu Langone Health

NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.

Locations

Patients applied

0 patients applied

Trial Officials

Howard B. Abikoff, PhD

Principal Investigator

C. Keith Conners

Principal Investigator

Laurence L. Greenhill, MD

Principal Investigator

Stephen P. Hinshaw, PhD

Principal Investigator

William E. Pelham, PhD

Principal Investigator

James M. Swanson, PhD

Principal Investigator

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials